Transformation of the Ukrainian pharmaceutical market – new opportunities and potential Pharmaceutical Industry Review, September No 4 (97) 2023
Ukraine is in the flames of war
Overview of the pharmaceutical market for the period from February 2022 to April 2023
KEY FACTS ABOUT THE ECONOMIC DEVELOPMENT OF UKRAINE1
Irina Gorlova / Ірина Горлова, director of the SMD company / директорка компанії SMD
Ukraine is one of the largest countries in Europe. Our country ranks 56th in the world in terms of absolute GDP, and 119th in terms of GDP per capita. According to the World Bank2
,
https://www.linkedin.com/in/ irinagorlova/
GDP per capita in 2021 was USD 4,836, the average annual growth over the past five years (2017 – 2021) was 16.5% per year. Ukraine has a powerful pharmaceutical industry, where more than 150 manufacturers work. The country is a member of the Pharmaceutical Inspection Cooperation Scheme (PIC/S)3
,
National Strategy 2030
https://nes2030.org. ua/#rec246061582 2
1
https://data.worldbank.org/indicator/NY.GDP.PCAP. CD?locations=UA 3
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is a non-binding, informal co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary use. It is open to any Authority having a comparable GMP inspection system. PIC/S presently comprises 54 Participating Authorities coming from all over the world (Europe, Africa, America, Asia and Australasia).
https://picscheme.org/en/about
which opens wide opportunities for simplifying the registration and import of medicines to the PIC/S countries. The capacities of domestic pharmaceutical manufacturers can be more actively used for import substitution of some drugs and medical products, as well as for export.
Market by product categories The category that "grew" during the war year is patient care products (+27% in monetary (UAH) terms, MAT for March 2023 vs. MAT for March 2022). The share of war-related categories increased the most among patient care products (surgical supplies, wound care products, artificial joints, etc.). The indicators of personal hygiene products were better than in the general market (-5% vs. -18%, respectively, in value (UAH) terms). This is most likely due to the "spill- over" of products from destroyed/ closed supermarkets and specialty shops to pharmacies in both the affected areas and those receiving the maximum number of internally displaced people (IDPs).
Market by sales channels The volume of government purchases has increased
8 BACK TO CONTENTS
www.promoboz.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
